YOLFTbeta
ChoA Pharmaceutical Co.Ltd

ChoA Pharmaceutical Co.Ltd

034940 · KQ · Healthcare / Drug Manufacturers - Specialty & Generic

1,486.00KRW-22.00 (-1.46%)

Price History

Full chart

Market Stats

Previous Close1,508.00
Open1,508.00
Day Range1,452.00 – 1,528.00
52-Week Range2,485.00 – 5,920.00
Volume12.20K
Market Cap16.33B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.52
50-Day Avg2,798.50
200-Day Avg3,868.75

About

ChoA Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea. The company produces approximately 200 medicines and health foods, including 30 internal ampoule products, such as Hepos, Fematin, Vasoclean, Mabis, etc. Its products include drugs for digestive, circulatory, and respiratory systems; vitamins, minerals, and nutrients; anti inflammation and analgesics; peripheral nervous system; gynecologic diseases; antibiotics, antigens, and anthelmintic; and antitumor, as well as other metabolite medicines. The company offers its products in the form of tablets, capsules, granules, syrups, solutions, drinkable ampoules, and sachets. It also provides medicine supply and pharmacy management services. The company exports its products to approximately 20 countries worldwide. The company was founded in 1964 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Sung-Hwan Cho
  • Employees269
  • HeadquartersACE Techno-Tower, Seoul, South Korea, 07299, Korea
  • Websitehttps://www.choa.co.kr

Leadership

  • Mr. Sung-Hwan ChoChief Executive Officer · b. 1970
  • Mr. Sungbae ChoChief Executive Officer

Financials

Income Statement

Currency: KRW2001-12-312002-12-312003-12-312004-12-312005-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue27.62B38.30B19.93B20.18B21.05B43.91B43.09B50.12B55.55B58.87B63.09B67.54B65.36B57.56B68.88B62.97B62.69B59.31B
Growth (%)-+38.68%-47.96%+1.22%+4.33%+108.61%-1.88%+16.32%+10.83%+5.97%+7.18%+7.05%-3.22%-11.93%+19.66%-8.57%-0.44%-5.40%
Cost of Revenue16.86B26.14B13.13B9.25B10.29B19.54B21.33B25.51B28.73B30.48B33.94B37.82B38.95B37.25B42.64B39.21B41.50B37.44B
Gross Profit------20.70B24.62B26.82B28.38B29.15B29.72B26.41B20.31B26.24B23.76B21.20B21.87B
Gross Margin------48.03%49.11%48.28%48.22%46.20%44.00%40.40%35.28%38.10%37.73%33.81%36.88%
Operating Expense------25.08B24.47B26.83B28.07B27.82B30.09B29.12B29.25B26.83B32.58B30.90B28.47B
Operating Income---2.40B476.80M1.65B-4.38B140.16M-4.83M317.66M1.33B-366.38M-2.72B-8.94B-589.31M-8.82B-9.70B-6.60B
Operating Margin---11.92%2.27%3.75%-10.17%0.28%-0.01%0.54%2.10%-0.54%-4.16%-15.53%-0.86%-14.01%-15.47%-11.13%
EBITDA--------------2.64B-7.57B-6.53B-2.80B
EBITDA Margin--------------3.83%-12.02%-10.41%-4.72%
Net Income---1.53B-1.80B-4.08B1.01B163.17M1.62B641.15M-905.31M-1.32B-8.04B560.69M-10.51B-9.60B-6.81B
Net Income Margin---7.58%-4.11%-9.46%2.02%0.29%2.76%1.02%-1.34%-2.02%-13.97%0.81%-16.70%-15.32%-11.47%
R&D-----1.52B2.05B1.66B1.72B1.66B1.57B-1.54B1.42B1.30B2.18B1.56B1.16B
R&D as % of Total Revenue-----3.45%4.77%3.30%3.10%2.83%2.48%-2.36%2.47%1.89%3.47%2.49%1.96%
Interest Expense000000000000610.72M375.65M676.44M979.33M1.12B1.19B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.93%0.65%0.98%1.56%1.78%2.01%

Balance Sheet

Currency: KRW2001-12-312002-12-312003-12-312004-12-312005-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets73.54B60.60B49.39B37.72B53.70B70.82B74.05B74.35B75.10B83.52B84.04B86.74B82.38B80.51B85.64B74.22B71.32B64.68B
Total Liabilities44.56B37.12B34.59B21.78B21.36B20.19B27.96B27.19B27.26B29.34B30.08B33.69B24.07B30.59B32.80B35.46B39.94B42.92B
Total Equity28.98B23.48B14.80B15.94B32.34B51.18B46.72B47.86B47.84B54.18B53.96B53.06B58.30B49.92B52.84B40.99B31.38B25.01B
Cash2.22B1.50B2.93B2.69B2.75B5.50B3.94B4.18B2.67B10.55B10.12B10.02B4.15B19.13M27.18M2.05B1.73M2.32B
Total Debt---------16.67B6.55B8.93B5.80B-----
Net Debt------------3.99B8.05B11.93B13.61B20.68B22.66B

Cash Flow

Currency: KRW2002-12-312003-12-312004-12-312005-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow--3.57B-3.53B625.52M1.19B930.42M-675.51M2.04B4.16B1.92B-1.48B-1.44B-1.48B-4.47B-4.18B
Investing Cash Flow5.40B-8.79B---7.99B-785.60M-1.87B823.99M-1.42B-2.37B-4.04B-1.87B-1.55B731.38M-1.80B-
Financing Cash Flow-4.22B-16.57B1.90B5.73B-149.14M-598.01M7.85B-1.20B-2.09B-3.83B4.82B1.81B-1.69B6.19B-
Capital Expenditure2.15B1.03B512.47M428.54M1.07B5.64B1.78B2.30B412.54M1.97B1.39B3.60B3.86B2.92B942.66M780.42M1.14B
Free Cash Flow----------1.46B-1.72B-5.34B-4.36B-2.42B-5.25B-5.32B
Dividends Paid-----134.60M-----------
FCF to OCF----------35.19%-89.45%361.00%302.50%163.90%117.47%127.29%

Earnings

Report DateMar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Feb 23, 2017May 15, 2017Aug 13, 2017Nov 14, 2017Feb 23, 2018May 15, 2018Nov 13, 2018Feb 21, 2019May 15, 2019Aug 14, 2019Nov 14, 2019Feb 24, 2020Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------------------------------------------------------------------
EPS Actual-53.1686.6275.26-287.3988.0531.14152.5219.55106.086.0535.537.79110.2466.7765.02-95.41121.25227.77-88.96-185.97-86.66-358.1521.6618.9461.7876.3424.832.3625.39-4.75-12.8923.9714.5227.0013.2924.43-66.1012.115.35-24.22-25.22-146.38110.6832.50-220.08-204.25-291.74-280.85-536.40-188.89-133.4118.90393.8927.25-123.76-408.66-1191.79-246.68-233.09-438.17-632.18-331.33-228.43-44.21-494.454.2280.66
Surprise-------------------------------------------------------------------
Timing-----------------------------Pre-marketPre-marketAfter-hours-Pre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-market--------------------------

Key Statistics & Ratios

Market Cap16.33B
Enterprise Value41.13B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.27
Price / Book0.46
Revenue (TTM)61.16B
Gross Profit (TTM)22.57B
EBITDA-1.83B
Profit Margin-4.60%
Operating Margin-0.15%
Return on Equity-11.81%
Return on Assets-3.66%
Shares Outstanding6.20M
Shares Float4.96M
Beta0.52
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20011×
240.80Jan 2, 2001

Stock Splits

  • Aug 27, 20261:5
  • Jul 5, 20052528:2435
  • Apr 21, 200310:1